10.1016/j.omto.2020.03.013 153 LiuY.LiangX.DongW.FangY.LvJ.ZhangT.et al
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
Collectively, this study presents a biomimetic nanoplatform for placenta-targeted delivery of bioactive compounds, offering a promising strategy for modulating placental dysfunction and advancing therapeutic approaches for PE and related placental disorders
SAMe and methionine require context Methionine or SAMe may be useful in selected undermethylated patients but may be inappropriate with elevated homocysteine, high SAH or an uncertain methylation pattern
However, genetic mutations and modern ills like poor diet, chronic stress, and exposure to toxins can affect the body's ability to manufacture adequate levels of glutathione and lead to glutathione deficiency